Primary record
(6aR,6bS,8aS,8bS,11aR,12aS,12bS)-8b-(2-Hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6b,8,8a,8b,11a,12,12a,12b-octahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxole-4,7(2H,6aH)-dione (Budesonide Impurity)
- 库存
- 5,759 克
- 纯度
- 99.7 %
- CAS
- 216453-74-6
化合物标识与属性
- CAS
- 216453-74-6
- PubChem CID
- 91810638
- SMILES
- CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4C(=O)C[C@@]3([C@@]2(O1)C(=O)CO)C)C
- Canonical SMILES
- CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4C(=O)C[C@]3(C)[C@]2(C(=O)CO)O1
名称与同义词
- 11-Keto budesonide
- Budesonide-11-keto
- 11-Ketobudesonide
- 216453-74-6
- Budesonide EP Impurity L
- RefChem:1057368
- 4H40LJ213Z
- BUDESONIDE IMPURITY L
- Budesonide Related Compound L
- UNII-4H40LJ213Z
- 11-Keto budesonide (mixture of diastereomers)
- C25H32O6
- 11-Keto Budesonide(Mixture of Diastereomers)
- 11-KETOBUDESONIDE [USP IMPURITY]
- FK146163
- BUDESONIDE IMPURITY L [EP IMPURITY]
- CS-0166428
- Budesonide EP Impurity L (Mixture of Epimer)
- BUDESONIDE RELATED COMPOUND L [USP-RS]
- F988307
- BUDESONIDE RELATED COMPOUND L [USP IMPURITY]
- Q27259582
- (6aR,6bS,8aS,8bS,11aR,12aS,12bS)-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,6a,6b,8,8a,8b,11a,12,12a,12b-decahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxole-4,7(2H)-dione
- (16alpha)-16,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione
- (6aR,6bS,8aS,8bS,11aR,12aS,12bS)-8b-(2-Hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6b,8,8a,8b,11a,12,12a,12b-octahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxole-4,7(2H,6aH)-dione (Budesonide Impurity)
- Pregna-1,4-diene-3,11,20-trione, 16,17-(butylidenebis(oxy))-21-hydroxy-, (16alpha)-
- (1S,2S,4R,8S,9S,12S,13R)-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-11,16-dione
- Budesonide EP Impurity L (11-Keto Budesonide, Mixture Of Diastereomers)
- Budesonide Impurity L (11-Keto Budesonide, Mixture of Diastereomers)
- (16)-16,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione
- (16|A)-16,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione
- (16a)-16,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione
- 16.ALPHA.,17-(BUTYLIDENEBIS(OXY))-21-HYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE
- 16alpha,17-[(1RS)-Butylidene-bis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione
- (6aR,6bS,8aS,8bS,11aR,12aS,12bS)-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6b,8,8a,8b,11a,12,12a,12b-octahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxole-4,7(2H,6aH)-dione
- 16a,17-[(1RS)-Butylidene-bis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione; Budesonide Imp. L (EP); Budesonide Related Compound L; Budesonide Impurity L
- PREGNA-1,4-DIENE-3,11,20-TRIONE, 16,17-(BUTYLIDENEBIS(OXY))-21-HYDROXY-, (16.ALPHA.)-